H-1B sponsorship profile: Saptalis Pharmaceuticals, LLC. Across U.S. Department of Labor LCA disclosures, Saptalis Pharmaceuticals, LLC filed 20 Labor Condition Applications covering 20 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (20 certified of 20 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Saptalis Pharmaceuticals, LLC’s H-1B petitions range from $59,197 at the low end to $135,200 at the high end, with a petition-weighted average of $73,074. That range reflects the mix of occupations the company sponsors, led by Regulatory Affairs Associate (4 petitions at $59,197 avg), followed by Associate Analytical Chemist and Analytical Scientist II/Group Leader. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Saptalis Pharmaceuticals, LLC is headquartered in Hauppauge, NY under NAICS code 32541, and places H-1B workers across 1 state, most heavily in NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Saptalis Pharmaceuticals, LLC ranks. By H-1B petition volume, Saptalis Pharmaceuticals, LLC is #10,148 of 119,880 employers nationally and #794 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.